Survey reveals major gaps in cardio-oncology training
An international survey presented at the ESC Cardio-Oncology 2026 conference reveals significant gaps in specialized training for cardio-oncology. The study aims to improve educational strategies to manage the cardiovascular side effects of modern cancer treatments.
Why it matters
As cancer survival rates improve, addressing the cardiovascular toxicity of treatments is becoming a critical priority for long-term patient care.
An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance. These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European Society of Cardiology's Council of Cardio-Oncology.
The content is a straightforward report on medical research and professional training standards.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in